COVID-19 outcomes of venovenous extracorporeal membrane oxygenation for acute respiratory failure vs historical cohort of non-COVID-19 viral infections.
Sagar B DaveRonald RabinowitzAakash ShahAli TabatabaiSamuel M GalvagnoMichael A MazzeffiRaymond RectorDavid J KaczorowskiThomas M ScaleaJay MenakerPublished in: Perfusion (2022)
COVID-19 patients supported with VV ECMO have a higher mortality than non-COVID-19 patients. While COVID-19 survivors had significantly longer VV ECMO runs than non-COVID-19 survivors, HLOS was similar. This data add to a growing body of literature supporting the use of ECMO for potentially reversible causes of respiratory failure.
Keyphrases
- respiratory failure
- extracorporeal membrane oxygenation
- sars cov
- coronavirus disease
- acute respiratory distress syndrome
- mechanical ventilation
- respiratory syndrome coronavirus
- systematic review
- young adults
- type diabetes
- machine learning
- adipose tissue
- risk factors
- cardiovascular events
- coronary artery disease
- insulin resistance
- glycemic control
- data analysis